Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker WSBC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Scott A. Love EVP - Wealth Management | WSBC WesBanco, Inc. | Sale | 1,500 | $40.12 | $60.2K Sale | Form 4 ↗ |
| Nov 5, 2026 | Scott A. Love EVP - Wealth Management | WSBC WesBanco, Inc. | Sale | 1,500 | $40.13 | $60.2K Sale | Form 4 ↗ |
| Aug 24, 2026 | Denise H. Knouse-Snyder Director | WSBC WesBanco, Inc. | Sale | 3,070 | $40.89 | $125.5K Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 1,100 | $42.08 | $46.3K Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 700 | $42.07 | $29.4K Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 200 | $42.06 | $8,412 Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 2,000 | $42.05 | $84.1K Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 213 | $42.05 | $8,957 Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 787 | $42.05 | $33.1K Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 1,000 | $42.06 | $42.1K Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 1,000 | $42.06 | $42.1K Sale | Form 4 ↗ |
| Aug 11, 2026 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Sale | 1,000 | $42.06 | $42.1K Sale | Form 4 ↗ |
| Jul 29, 2026 | Jayson M. Zatta SEVP & Chief Banking Officer | WSBC WesBanco, Inc. | Sale | 12,500 | $41.80 | $522.5K Sale | Form 4 ↗ |
| Jul 28, 2026 | Jan Pattishall-Krupinski SEVP - Chief Admin Officer | WSBC WesBanco, Inc. | Sale | 2,250 | $41.45 | $93.3K Sale | Form 4 ↗ |
| Jul 28, 2026 | Jan Pattishall-Krupinski SEVP - Chief Admin Officer | WSBC WesBanco, Inc. | Sale | 500 | $41.91 | $21.0K Sale | Form 4 ↗ |
| Jul 28, 2026 | Jan Pattishall-Krupinski SEVP - Chief Admin Officer | WSBC WesBanco, Inc. | Sale | 2,000 | $41.91 | $83.8K Sale | Form 4 ↗ |
| Jul 27, 2026 | Kimberly L. Griffith SEVP - Human Resources | WSBC WesBanco, Inc. | Sale | 1,500 | $41.22 | $61.8K Sale | Form 4 ↗ |
| Jul 27, 2026 | Kimberly L. Griffith SEVP - Human Resources | WSBC WesBanco, Inc. | Sale | 1,000 | $41.19 | $41.2K Sale | Form 4 ↗ |
| Jul 27, 2026 | Kimberly L. Griffith SEVP - Human Resources | WSBC WesBanco, Inc. | Sale | 1,000 | $41.19 | $41.2K Sale | Form 4 ↗ |
| Jul 27, 2026 | Kimberly L. Griffith SEVP - Human Resources | WSBC WesBanco, Inc. | Sale | 2,250 | $41.19 | $92.7K Sale | Form 4 ↗ |
| Jul 27, 2026 | Kimberly L. Griffith SEVP - Human Resources | WSBC WesBanco, Inc. | Sale | 1,125 | $41.19 | $46.3K Sale | Form 4 ↗ |
| Jun 22, 2026 | Jan Pattishall-Krupinski SEVP - Chief Admin Officer | WSBC WesBanco, Inc. | Sale | 2,250 | $36.72 | $82.6K Sale | Form 4 ↗ |
| Jun 22, 2026 | Jan Pattishall-Krupinski SEVP - Chief Admin Officer | WSBC WesBanco, Inc. | Sale | 2,250 | $36.70 | $82.6K Sale | Form 4 ↗ |
| May 8, 2026 | Scott A. Love EVP - Wealth Management | WSBC WesBanco, Inc. | Buy | 400 | $34.08 | $13.6K Buy | Form 4 ↗ |
| Apr 27, 2026 | Joseph R. Robinson Director | WSBC WesBanco, Inc. | Buy | 800 | $34.51 | $27.6K Buy | Form 4/A ↗ |
| Apr 27, 2026 | Joseph R. Robinson Director | WSBC WesBanco, Inc. | Buy | 200 | $34.52 | $6,904 Buy | Form 4/A ↗ |
| Apr 23, 2026 | Louis Michael Altman Director | WSBC WesBanco, Inc. | Buy | 3,000 | $33.72 | $101.2K Buy | Form 4 ↗ |
| Apr 23, 2026 | Lee J. Burdman Director | WSBC WesBanco, Inc. | Buy | 3,000 | $33.60 | $100.8K Buy | Form 4 ↗ |
| Mar 18, 2026 | Kerry M. Stemler Director | WSBC WesBanco, Inc. | Buy | 5 | $32.77 | $164 Buy | Form 4 ↗ |
| Mar 18, 2026 | Kerry M. Stemler Director | WSBC WesBanco, Inc. | Buy | 450 | $32.77 | $14.7K Buy | Form 4 ↗ |
| Mar 18, 2026 | Kerry M. Stemler Director | WSBC WesBanco, Inc. | Buy | 10 | $32.73 | $327 Buy | Form 4 ↗ |
| Mar 18, 2026 | Kerry M. Stemler Director | WSBC WesBanco, Inc. | Buy | 475 | $32.77 | $15.6K Buy | Form 4 ↗ |
| Dec 3, 2025 | F. Eric Nelson Jr. Director | WSBC WesBanco, Inc. | Sale | 752 | $33.37 | $25.1K Sale | Form 4 ↗ |
| Oct 30, 2025 | Zahid Afzal Director | WSBC WesBanco, Inc. | Buy | 2 | $30.10 | $60.2 Buy | Form 4 ↗ |
| Oct 30, 2025 | Zahid Afzal Director | WSBC WesBanco, Inc. | Buy | 3,319 | $30.11 | $99.9K Buy | Form 4 ↗ |
| Sep 17, 2025 | Daniel K Weiss SEVP & Chief Financial Officer | WSBC WesBanco, Inc. | Buy | 4,000 | $25.00 | $100.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Joseph R. Robinson Director | WSBC WesBanco, Inc. | Buy | 8,000 | $25.00 | $200.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Gregory S. Proctor Jr. Director | WSBC WesBanco, Inc. | Buy | 2,000 | $25.00 | $50.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | F. Eric Nelson Jr. Director | WSBC WesBanco, Inc. | Buy | 8,000 | $25.00 | $200.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Scott A. Love EVP - Wealth Management | WSBC WesBanco, Inc. | Buy | 1,000 | $25.00 | $25.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | D. Bruce Knox Director | WSBC WesBanco, Inc. | Buy | 8,000 | $25.00 | $200.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Jeffrey H. Jackson President & CEO, Director | WSBC WesBanco, Inc. | Buy | 4,000 | $25.00 | $100.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Robert H. Friend EVP & CCO | WSBC WesBanco, Inc. | Buy | 800 | $25.00 | $20.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | James W. Cornelsen Director | WSBC WesBanco, Inc. | Buy | 10,000 | $25.00 | $250.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Todd Clossin Director | WSBC WesBanco, Inc. | Buy | 8,000 | $25.00 | $200.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | John Bookmyer Director | WSBC WesBanco, Inc. | Buy | 2,000 | $25.00 | $50.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Louis Michael Altman Director | WSBC WesBanco, Inc. | Buy | 1,000 | $25.00 | $25.0K Buy | Form 4 ↗ |
| Sep 17, 2025 | Rosie Allen-Herring Director | WSBC WesBanco, Inc. | Buy | 800 | $25.00 | $20.0K Buy | Form 4 ↗ |
| May 22, 2025 | Kerry M. Stemler Director | WSBC WesBanco, Inc. | Buy | 275 | $30.90 | $8,498 Buy | Form 4 ↗ |
| May 22, 2025 | Kerry M. Stemler Director | WSBC WesBanco, Inc. | Buy | 270 | $30.90 | $8,343 Buy | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:18 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances